Skip to content

Study Details

Staccato Alprazolam: A Study Drug and Device for People with Stereotypical Prolonged Seizures

(IRB#: IRB_00154360)

Seizure emergencies can be long-lasting and hard to control with serious results. Typically, these seizures require drugs to help stop them from happening. Staccato Alprazolam is a new drug and tool combined to help stop this seizure. Research is needed to know the safety and effectiveness of this treatment. The information we learn may aid future patients.


  • All genders
  • Over 18 years old
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: Over 18 years old

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 12 years and older
  • Ages 12-17 years old must have a caregiver
  • Epilepsy diagnosis
  • Participant may need to use specific birth control during the study
  • In-person at the University of Utah

Exclusion Criteria

  • Physical or mental disability that prevents being in the study
  • History of drug or alcohol abuse
  • History or current diagnosis of Asthma
  • In another study that is testing a device
  • Pregnant

Will I be paid for my time?


For more information contact:

Laura Beeler


IRB#: IRB_00154360

PI: Angela Peters

Department: NEUROLOGY

Approval Date: 2022-10-20 06:00:00

Study Categories: Brain Health Studies

Specialties: Neurology

Last Updated: 6/8/23